Cilazapril and dietary gamma-linolenic acid prevent the deficit in sciatic nerve conduction velocity in the streptozotocin diabetic rat

Journal of Diabetes and its Complications

Volumn 12, Issue 2, 1998, Pages 65-73

  Burnard, Sharon L ^a   McMurchie, Edward J ^a   Leifert, Wayne R ^a   Patten, Glen S ^a   Muggli, Reto ^b   Raederstorff, Daniel ^b   Head, Richard J ^a  

^a CSIRO   (Australia)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID; FRUCTOSE; GAMMA LINOLENIC ACID; GLUCOSE; INOSITOL; LINOLEIC ACID; MANNOSE; OLIVE OIL; SORBITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIETARY INTAKE; ENDONEURIUM; MALE; NERVE CONDUCTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES;

EID: 0031959030     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(97)00072-X     Document Type: Article

References (39)

1. Greene DA, De Jesus PV Jr., Winegrad AI Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J Clin Invest. 55:1975;1326-1336.
2. Cameron NE, Cotter MA, Robertson S Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarisation in streptozotocin-induced diabetic rats. Diabetes. 40:1991;532-539.
3. Mayer JH, Tomlinson DR Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia. 25:1983;433-438.
4. Greene DA, Lattimer SA Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Diabetes. 33:1984;712-716.
5. +-ATPase activity, and vascular supply in STZ-rats. Diabetes. 40:1991;1652-1658.
6. Cameron NE, Cotter MA, Low PA Nerve blood flow in early experimental diabetes in rats. Relation to conduction deficits Am J Physiol. 261:1991;E1-E8.
7. Eck MG, Wynn JO, Carter WJ, Faas FH Fatty acid desaturation in experimental diabetes mellitus. Diabetes. 28:1979;479-485.
8. Poisson JP Comparative in vivo and in vitro study of the influence of experimental diabetes on rat liver linoleic acid Δ6- and Δ5-desaturation. Enzyme. 34:1985;1-14.
9. Moncada S, Vane JR Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 300:1979;1142-1147.
10. Ward KK, Low PA, Schmelzer JD, Zochodne DW Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain. 112:1989;197-208.
11. Tomlinson DR, Robinson JP, Compton AM, Keen P Essential fatty acid treatment - effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia. 32:1989;655-659.
12. Dines KC, Cameron NE, Cotter MA Comparison of the effects of evening primrose oil and triglycerides containing γ-linolenic acid on nerve conduction and blood flow in diabetic rats. J Pharmacol Exp Ther. 273:1995;49-55.
13. Cameron NE, Cotter MA, Robertson S Rapid reversal of a motor nerve conduction deficit in streptozotocin-diabetic rats by the angiotensin converting enzyme inhibitor lisinopril. Acta Diabetologica. 30:1993;46-48.
14. Stevens EJ, Lockett MJ, Carrington AL, Tomlinson DR Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia. 36:1993;397-401.
15. Young MJ, Veves A, Smith JV, Walker MG, Boulton AJM Restoring lower limb blood flow improves conduction velocity in diabetic patients. Diabetologia. 38:1995;1051-1054.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall R Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
17. Tomlinson DR, Moriarty RJ, Mayer JH Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor sorbinil. Diabetes. 33:1984;470-476.
18. Bligh EC, Dyer WJ A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 37:1959;911-917.
19. Brenner RR Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res. 20:1982;41-44.
20. +-ATPase in diabetic nerve by protein kinase C agonists. Am J Physiol. 256:1989;E264-E269.
21. Julu POO Essential fatty acids prevent slowed nerve conduction in streptozotocin diabetic rats. J Diabet Complications. 2:1988;185-188.
22. Horrobin DF Fatty acid metabolism in health and disease. The role of Δ-6-desaturase Am J Clin Nutr. 57(suppl):1993;732S-737S.
23. Cameron NE, Cotter MA Comparison of the effects of ascorbyl γ-linolenic acid and γ-linolenic acid in the correction of neurovascular deficits in diabetic rats. Diabetologia. 39:1996;1047-1054.
24. + pump in streptozotocin-diabetic rats. Br J Pharmacol. 105:1992;355-360.
25. Keen H, Payan J, Allawi Jet al. Treatment of diabetic neuropathy with γ-linolenic acid. Diabetes Care. 16:1993;8-15.
26. Jamal GA, Carmichael H The effect of γ-linolenic acid on human diabetic peripheral neuropathy. A double-blind placebo-controlled trial Diabetic Med. 7:1990;319-323.
27. Newrick PG, Wilson AJ, Jakubowski JA, Boulton AJM, Ward JD Sural nerve oxygen tension in diabetes. B M J. 293:1986;1053-1054.
28. Tuck RR, Schmelzer JD, Low PA Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain. 107:1984;935-950.
29. 2 dual blocker KDI-792. Prostaglandins Leukot Essent Fatty Acids. 53:1995;139-145.
30. Ward KK, Low PA, Schmelzer JD, Zochodne DW Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain. 112:1989;197-208.
31. Hotta N, Koh N, Sakakibara Fet al. Effects of beraprost sodium and insulin on the electroretinogram, nerve conduction, and nerve blood flow in rats with streptozotocin-induced diabetes. Diabetes. 45:1996;361-366.
32. Ueno Y, Koike H, Nakamura Y, Ochi Y, Annoh S, Nishio S Effects of beraprost sodium, a prostacyclin analogue, on diabetic neuropathy in streptozotocin-induced diabetic rats. Jpn J Pharmacol. 70:1996;177-182.
33. Cotter MA, Dines KC, Cameron NE Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost. Naunyn Schmiedebergs Arch Pharmacol. 347:1993;534-540.
34. Horrobin DF The effects of gamma-linolenic acid on breast pain and diabetic neuropathy. Possible non-eicosanoid mechanisms Prostaglandins Leukot Essent Fatty Acids. 48:1993;101-104.
35. Cameron NE, Cotter MA, Robertson S Angiotensin converting enzyme inhibition prevents the development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia. 35:1992;12-18.
36. Helin K, Stoll M, Meffert S, Stroth U, Unger T The role of angiotensin receptors in cardiovascular diseases. Ann Med. 29:1997;23-29.
37. Barnes JM, Steward LJ, Barber PC, Barnes NM Identification and characterisation of angiotensin II receptor subtypes in human brain. Eur J Pharmacol. 230:1993;251-258.
38. Dyer SM, Taylor DA, Bexis S, Hime NJ, Frewin DB, Head RJ Identification of a non endothelial cell thromboxane-like constrictor response and its interaction with the renin-angiotensin system in the aorta of spontaneously hypertensive rats. J Vasc Res. 31:1994;52-60.
39. Cameron NE, Cotter MA, Hohman TC Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia. 39:1996;172-182.